Winslow Evans & Crocker’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Winslow Evans & Crocker’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$0	Buy	+2	New	+$63	﹤0.01%	1369
2020 Q1	–	Sell	-3	Closed	-$2K	–	1185
2019 Q4	$2K	Hold	3	–	–	﹤0.01%	1126
2019 Q3	$2K	Hold	3	–	–	﹤0.01%	1125
2019 Q2	$2K	Hold	3	–	–	﹤0.01%	1117
2019 Q1	$2K	Hold	3	–	–	﹤0.01%	1287
2018 Q4	$2K	Hold	3	–	–	﹤0.01%	1071
2018 Q3	$2K	Hold	3	–	–	﹤0.01%	1082
2018 Q2	$2K	Hold	3	–	–	﹤0.01%	1093
2018 Q1	$1.57K	Hold	3	–	–	﹤0.01%	1043
2017 Q4	$1.98K	Hold	3	–	–	﹤0.01%	1034
2017 Q3	$2.59K	Sell	3 -2	-40%	-$1.58K	﹤0.01%	1003
2017 Q2	$4.2K	Hold	5	–	–	﹤0.01%	1088
2017 Q1	$3.54K	Hold	5	–	–	﹤0.01%	1079
2016 Q4	$3.63K	Hold	5	–	–	﹤0.01%	1074
2016 Q3	$4.8K	Hold	5	–	–	﹤0.01%	1068
2016 Q2	$7.16K	Hold	5	–	–	﹤0.01%	960
2016 Q1	$6.18K	Hold	5	–	–	﹤0.01%	981
2015 Q4	$6.48K	Hold	5	–	–	﹤0.01%	1003
2015 Q3	$7.27K	Hold	5	–	–	﹤0.01%	959
2015 Q2	$11.1K	Hold	5	–	–	﹤0.01%	909
2015 Q1	$14.9K	Hold	5	–	–	﹤0.01%	801
2014 Q4	$16.6K	Hold	5	–	–	﹤0.01%	779
2014 Q3	$17.7K	Hold	5	–	–	0.01%	767
2014 Q2	$19.3K	Hold	5	–	–	0.01%	687
2014 Q1	$20.4K	Hold	5	–	–	0.01%	669
2013 Q4	$19K	Buy	+5	New	+$18.9K	0.01%	719

Other funds holding FRTX

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Winslow Evans & Crocker's FRTX Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2020: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1369 among its holdings. This is a return to the name: Winslow Evans & Crocker previously reported a position in FRTX as recently as Q4 2019.

Winslow Evans & Crocker first reported a position in FRTX in Q4 2013 and has held it in 26 quarters since. The position peaked at $20.4K in Q1 2014. 25 funds tracked by Wall St. Rank hold FRTX as of Q4 2020.

Winslow Evans & Crocker held 2 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q4 2020.
Fresh Tracks Therapeutics, Inc. Common Stock was a new Winslow Evans & Crocker position in Q4 2020.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1369 holding.
Winslow Evans & Crocker first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and has held it in 26 quarters since.
Winslow Evans & Crocker's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $20.4K in Q1 2014.
25 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.